Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Anders Jarstad
Introduction
Anders Jarstad is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of neurotoxin purification and formulation. With a total of 2 patents, his work focuses on enhancing the safety and efficacy of neurotoxin applications in therapeutic settings.
Latest Patents
Jarstad's latest patents include a method of purifying botulinum toxin and a liquid neurotoxin formulation stabilized with tryptophan or tyrosine. The purification method involves commercial-scale techniques that utilize filtration and chromatographic separation steps. This process results in a high-purity botulinum toxin composition that is free from complexes and animal products. The method allows for the production of highly active botulinum toxin protein molecules without the need for reconstitution by the end user. His second patent relates to stable liquid neurotoxin formulations that are free of animal proteins. These formulations include a surfactant and an amino acid, either tryptophan or tyrosine, and are designed to remain stable for two months, making them suitable for therapeutic use.
Career Highlights
Throughout his career, Jarstad has worked with prominent companies in the pharmaceutical industry, including Ipsen Biopharm Limited and Galderma Holding SA. His expertise in neurotoxin research has positioned him as a valuable contributor to advancements in this field.
Collaborations
Some of his notable coworkers include Ulf Stahl and Anna Friis, who have collaborated with him on various projects related to neurotoxin research and development.
Conclusion
Anders Jarstad's innovative work in the purification and formulation of neurotoxins has the potential to significantly impact therapeutic applications. His contributions reflect a commitment to advancing safety and efficacy in medical treatments.